Moody’s assigns ‘Baa2’ rating to Boston Medical Center’s bonds

Moody’s Investors Service has assigned a “Baa2” rating to Boston Medical Center’s proposed $180 million of series 2016E revenue bonds.

Advertisement

The rating assignment is based on several factors, including Boston Medical Center’s key role as a healthcare provider in the area and as a provider of health insurance services through an affiliated insurance plan.

BMC also faces challenges, including a payer mix heavily weighted toward governmental payers.

The outlook is stable, reflecting Moody’s Investors Services’ view that BMC will continue to receive supplemental funding and generate adequate margins.

More articles on healthcare finance:
CMS offers bundled payment webinar
Power plant tax dispute risks shuttering Texas community hospital: 5 things to know
5 findings on Brexit’s anticipated effect on NHS

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.